More tools:Markets·Screener·Research·Chat

PAVmed Inc. Common Stock (PAVM) Financial Statements

PAVmed Inc. Common Stock
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00DGWP3H1
XNAS · usd
4.72▼ 0.56 (-10.61%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close5.28
Day's Range4.70 – 5.40
52-Week Range0.21 – 28.44
Volume98.9K
Avg Volume31.2K
Share Statistics
Shares Outstanding
Employees41
ExchangeXNAS
Listed2016-04-28
Share count as of August 13, 2026
Loading Income Statement…
Key questions about PAVmed Inc. Common Stock (PAVM)
What is PAVmed Inc. Common Stock's Market Cap?
PAVmed Inc. Common Stock's Market Cap is $37.7M, based on as-reported figures from SEC (XBRL) filings.
What is PAVmed Inc. Common Stock's Enterprise Value?
PAVmed Inc. Common Stock's Enterprise Value is $49.0M, based on as-reported figures from SEC (XBRL) filings.
What is PAVmed Inc. Common Stock's Price / Sales?
PAVmed Inc. Common Stock's Price / Sales is 337.0×, based on as-reported figures from SEC (XBRL) filings.
What is PAVmed Inc. Common Stock's EV / Revenue?
PAVmed Inc. Common Stock's EV / Revenue is 437.1×, based on as-reported figures from SEC (XBRL) filings.
What is PAVmed Inc. Common Stock's EV / EBITDA?
PAVmed Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is PAVmed Inc. Common Stock's Revenue (TTM)?
PAVmed Inc. Common Stock's Revenue (TTM) is $112.0K, based on as-reported figures from SEC (XBRL) filings.
What is PAVmed Inc. Common Stock's Net Income (TTM)?
PAVmed Inc. Common Stock's Net Income (TTM) is -$12.1M, based on as-reported figures from SEC (XBRL) filings.
What is PAVmed Inc. Common Stock's EBITDA?
PAVmed Inc. Common Stock's EBITDA is -$26.6M, based on as-reported figures from SEC (XBRL) filings.
What is PAVmed Inc. Common Stock's Diluted EPS (TTM)?
PAVmed Inc. Common Stock's Diluted EPS (TTM) is -1.51, based on as-reported figures from SEC (XBRL) filings.
What is PAVmed Inc. Common Stock's EBITDA Margin?
PAVmed Inc. Common Stock's EBITDA Margin is -23771.4%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+312.5%+420.0%-99.5%
Operating expenses:
Cost of revenue
Sales and marketing
General and administrative
Research and development
Total operating expenses
% of revenue21378.8%13182.7%96980.0%
Operating loss
% of revenue-21278.8%-13082.7%-96880.0%
Other income (expense):
Interest income——
Interest expense
Change in fair value - equity method investment——
Change in fair value - Senior Secured Convertible Notes
Debt extinguishments loss - Senior Secured Convertible Notes——
Change in fair value - warrant liability——
Change in fair value - rights liability——
Management fee income
Grant income
Other expense——
Other income (expense), net
Income (loss) before provision for income tax
Provision for income taxes——
Net income (loss) before noncontrolling interests
% of revenue-19993.9%-5301.9%-120220.0%
Net loss attributable to the noncontrolling interests
Net income (loss) attributable to PAVmed
% of revenue-16315.2%-2428.8%-107660.0%
Less: Series B Convertible Preferred Stock dividends earned—
Net income (loss) attributable to PAVmed common stockholders
Net income (loss) per share attributable to PAVmed common stockholders – basic (in dollars per share)—
Net income (loss) per share attributable to PAVmed common stockholders – diluted (in dollars per share)—